On Monday, shares of Asian diagnostic kit makers and vaccine producers saw a significant rise. This increase follows a global trend, as researchers recently discovered a new coronavirus in bats. This virus utilizes the same cellular gateway as the virus responsible for Covid-19.
The groundbreaking study conducted by researchers at the Wuhan Institute of Virology in China was published last week in the esteemed journal Cell. The findings suggest that this newly identified virus has the potential to spread from animals to humans. However, it is crucial to note that the virus has not yet been detected in humans.
The discovery of this new virus has raised concerns and prompted a rally in the stocks of companies involved in the production of diagnostic kits and vaccines. The study underscores the importance of continued vigilance and research in understanding how these viruses can impact human health.
The news of the new coronavirus discovery has resonated globally, leading to increased interest in the biotechnology sector. Investors are closely monitoring developments, as the potential for cross-species transmission could have significant implications for public health strategies worldwide.
